1. Home
  2. DVA vs WES Comparison

DVA vs WES Comparison

Compare DVA & WES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • WES
  • Stock Information
  • Founded
  • DVA 1994
  • WES 2007
  • Country
  • DVA United States
  • WES United States
  • Employees
  • DVA N/A
  • WES N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • WES Natural Gas Distribution
  • Sector
  • DVA Health Care
  • WES Utilities
  • Exchange
  • DVA Nasdaq
  • WES Nasdaq
  • Market Cap
  • DVA 15.2B
  • WES 15.4B
  • IPO Year
  • DVA 1995
  • WES 2008
  • Fundamental
  • Price
  • DVA $147.01
  • WES $38.96
  • Analyst Decision
  • DVA Hold
  • WES Hold
  • Analyst Count
  • DVA 5
  • WES 9
  • Target Price
  • DVA $154.40
  • WES $38.00
  • AVG Volume (30 Days)
  • DVA 1.3M
  • WES 1.4M
  • Earning Date
  • DVA 05-01-2025
  • WES 02-26-2025
  • Dividend Yield
  • DVA N/A
  • WES 8.99%
  • EPS Growth
  • DVA 44.61
  • WES 54.62
  • EPS
  • DVA 10.73
  • WES 4.02
  • Revenue
  • DVA $12,815,550,000.00
  • WES $3,605,223,000.00
  • Revenue This Year
  • DVA $5.76
  • WES $5.35
  • Revenue Next Year
  • DVA $3.59
  • WES $5.40
  • P/E Ratio
  • DVA $13.70
  • WES $9.68
  • Revenue Growth
  • DVA 5.56
  • WES 16.06
  • 52 Week Low
  • DVA $125.64
  • WES $33.39
  • 52 Week High
  • DVA $179.60
  • WES $43.33
  • Technical
  • Relative Strength Index (RSI)
  • DVA 41.48
  • WES 42.80
  • Support Level
  • DVA $138.64
  • WES $37.51
  • Resistance Level
  • DVA $149.06
  • WES $40.95
  • Average True Range (ATR)
  • DVA 4.76
  • WES 1.12
  • MACD
  • DVA -0.71
  • WES -0.27
  • Stochastic Oscillator
  • DVA 42.77
  • WES 33.89

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About WES Western Midstream Partners LP Common Units Representing Limited Partner Interests

Western Midstream Partners LP is a US-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.

Share on Social Networks: